During 1999, serum samples were collected from beef cows on pastures in western Canada. Some of the herds had a history of confirmed abortions associated with Neospora caninum infection. All these samples were initially analyzed using a single application of 1 common commercial enzyme-linked immunosorbent assay (ELISA) for antibodies to N. caninum. From these initial results, 239 positive and 250 negative samples were randomly selected for further testing. This group of samples was retested using the 3 commercially available ELISA tests for N. caninum as per the manufacturer's recommendations. The agreement between 2 of the ELISAs was good ( ϭ 0.76); agreement of these 2 tests with the third test was much lower ( ϭ 0.46 and 0.60). Quantitative agreement between tests measured by intraclass correlation coefficients was also acceptable between the first 2 tests but was almost zero when the first 2 tests were compared with the third. This information is necessary to understand the differences in seroprevalence reported in different regions from laboratories using different methods.
Relatively little is known about the epidemiology of Neospora caninum in beef herds. Recently published reports from Canada 6,7 and the United States 1 have suggested both reproductive and productivity effects of this parasite. In many cases, the analyses have been conducted using different serological tests; therefore, interpretation and comparison of these reports become extremely difficult. Similarly, it is difficult to compare the results from beef cattle collected from western Canada with those of the many dairy cattle studies done in eastern Canada 5 because of the use of different serological tests.
During 1999, serum samples were collected from beef cows on community pastures in Saskatchewan and from cow-calf operations in Alberta. Some of the Alberta herds had a history of abortions associated with N. caninum infection. All these samples were initially analyzed using a commercial enzyme-linked immunosorbent assay (ELISA) test for antibodies to N. caninum (test A). From these initial results, 239 positive and 250 negative samples were randomly selected for further testing. These samples (n ϭ 489) were retested using the 2 commercially available ELISAs for N. caninum, currently available in Canadian laboratories (tests A and B), a,b and a third direct agglutination test used to explore potential productivity effects of N. caninum infection on feedlot performance (test C), c as per the manufacturer's recommendations. 3 Serum samples were collected from the median caudal vein using blood collection tubes with no additives. The blood samples were centrifuged at 1,000 ϫ g for 10 minutes, and the serum was pipetted off within 36 hours of sample collection. Samples were frozen at Ϫ20 C until the time of analysis.
All samples were initially analyzed using a commercially Later, all samples were retested with test A using 2 wells for each sample, according to manufacturer's instructions. Negative and positive controls supplied with the test kits were included in the test. The results were provided as a sample to positive ratio (S/P ratio). This is calculated by dividing the optical densities for the sample minus the negative control by the optical density values of the positive control minus the negative control. Positive animals were defined according to the manufacturer's recommendation of an S/P ratio of 0.5 or greater. Recently, a sensitivity of 97.6% and a specificity of 98.5% have been reported for this test. 8 Sera were then tested using a second commercially available ELISA (test B) b according to manufacturer's instructions. Each plate was run with positive and negative controls. The results were reported as sample to positive control optical density ratios. Positive samples were defined according the manufacturer's recommendations provided with the kits, with a sample to positive ratio (S/P) greater than 0.80 being considered positive (recommendations included with the kit used in 2000) and current recommendations of S/P values greater than or equal to 0.60 considered positive. Sensitivity values of 88.4% and 95.1% and specificity values of 92.9% and 100% have been recorded for a cutoff value of 0.50. 2, 8 Finally, sera were examined with a test based on direct agglutination of whole parasites by specific antibodies of N. caninum in the serum, nonspecific reactions being avoided by the presence of a reducing agent during the agglutination reaction (test C). c The test was carried out in microplates with 96 round-bottom wells. Fifty microliters of 4 sequential 2-fold dilutions (1/40, 1/80, 1/160, 1/320) of each serum to be analyzed was placed in 50 l of N. caninum suspension. The plates were stirred briefly and incubated at 30 C overnight. The presence of serum antibodies leads to the formation of parasitic agglutination as a shadow or complete carpet of agglutinated parasites macroscopically visible in The titers are given as the last dilution of the serum associated with parasite agglutination. For bovine serum, the positive threshold is 1/80. Sera with a titer of less than or equal to 1/40 are classified as negative. Titers of 1/80 are questionable, and titers greater than 1/160 are considered positive. The test is reported to have a sensitivity of 95% and a specificity of 95%. 1 All data were entered onto a commercial spreadsheet program. d Agreement between the test procedures was estimated using kappa coefficients e and 2-way mixed intraclass corre-lation coefficients for absolute agreement with 95% confidence intervals. f The difference between different testing procedures was examined using McNemar's chi square. f Lin's concordance coefficient was calculated to look at the absolute agreement between the results for the first test system, comparing only 1 well per sample with 2 wells per sample (test A). 4 The frequency of positive results was 48.9% (239/489) for test A (Fig. 1) The qualitative agreement on positive or negative classification between the single-well or 2-well approach to the test A assay done at 2 different times was excellent (, 0.96; 95% confidence interval, 0.87, 1.0). The agreement between test A (2 wells) and test B assay was lower but still reasonably good (, 0.78; 95% CI, 0.69-0.87). The kappa value for the comparison with test A (2-well test) increased to 0.88 (95% CI, 0.79-0.97) when the current cutoff value of 0.60 was used. The agreement on classification between either test A (, 0.46; 95% CI, 0.38-0.53) or test B (, 0.60; 95% CI, 0.52-0.69) and test C (Fig. 2) was much lower. The agreement with test B dropped to 0.50 (95% CI, 0.42-0.58) when the current cutoff value of 0.60 was used for the test B test. For this calculation, the doubtful tests on the test C assay were considered positive, giving a sample prevalence of 23.3% (114/489). This gave a higher level of agreement than when the doubtful tests were grouped with the negative results or when the doubtful (1/80) samples were omitted from the calculation. All combinations of test comparisons using McNemar's chi square identified significant differences in results (P Ͻ 0.01) Agreement among the quantitative results was also assessed across different test procedures (Table 1) . Lin's con- cordance coefficient comparing the reproducibility of the 2 methods for test A is 0.94 (95% CI, 0.93-0.95). Again, reliability between the 2 protocols for test A was good, as was agreement between test A and test B. However, the agreement between the quantitative values from these tests and the test C assay was substantially lower. There was no association between the intensity of the test C reaction and the results of the other 2 commercial ELISAs. Sensitivity and specificity have been previously reported for these assays. These reports have used a variety of ''gold standards'' including reference sera provided from other laboratories, competitive inhibition ELISA results from another laboratory, and the results of the immunofluorescence antibody test. 1, 2, 8 There is a lack of consistency across references in how the gold standard is defined, making the reliance on published values problematic. There are other limitations to generalizing from these reported values because some of the studies including both articles referenced here used cutoff values different from those currently recommended by the manufacturers.
Recently, other researchers 8 concluded that test A and test B ELISAs work equally well within their laboratory and reported kappa values measuring agreement between test A and test B and a third competitive ELISA but did not report the kappa value comparing the performance of the 2 commercial ELISAs with each other. To the knowledge of the authors, no other studies have looked at the agreement among all 3 assays, where the seroprevalence is near 50% with sufficient sample size to permit optimal estimates of kappa in the population of interest. No studies have looked at the difference in results when 1 well is used instead of 2 for test A; although not recommended by the manufacturer, the use of a single well produced very comparable results in this laboratory and resulted in substantial cost savings in a large field study. Also, no other researchers have reported agreement of the quantitative results. These data are necessary to explore the differences in seroprevalence and strength of association, with reproductive and productivity outcomes reported in different types of cattle and regions of North America. 
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